fluorodeoxyglucose f18 has been researched along with Amyloid Deposits in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (19.51) | 29.6817 |
2010's | 26 (63.41) | 24.3611 |
2020's | 7 (17.07) | 2.80 |
Authors | Studies |
---|---|
Baik, K; Jeon, S; Kang, SW; Lee, PH; Lee, YG; Park, M; Sohn, YH; Ye, BS; Yoon, SH | 1 |
Bhakta, S; Evans, NR; Gorey, S; Kelly, PJ; McCabe, JJ; Rudd, JHF | 1 |
Allegri, R; Barthélemy, NR; Bateman, RJ; Benzinger, TLS; Berman, SB; Buckles, V; Chhatwal, J; Fagan, AM; Farlow, M; Fox, NC; Gabelle, A; Goate, AM; Gordon, BA; Graff-Radford, NR; Hassenstab, J; Ikeuchi, T; Joseph-Mathurin, N; Jucker, M; Karch, CM; Lehmann, S; Levin, J; Li, Y; Martins, RN; Masters, CL; McDade, E; Mendez, PC; Mori, H; Morris, JC; Noble, J; O'Connor, A; Perrin, RJ; Salloway, S; Sato, C; Schofield, PR; Shimada, H; Shoji, M; Suzuki, K; Xiong, C | 1 |
da Silva, AR; Diao, Y; Jelescu, IO; Lanz, B; Pierzchala, K; Poitry-Yamate, C; Tristão Pereira, C; Yin, T | 1 |
Baker, SL; Boxer, A; DeCarli, C; Edwards, L; Gorno-Tempini, M; Grinberg, LT; Hepker, M; Huang, E; Hwang, JL; Iaccarino, L; Jagust, WJ; Janabi, M; La Joie, R; Lesman-Segev, OH; Lobach, I; Miller, BL; Olichney, J; Pham, J; Rabinovici, GD; Rosen, HJ; Seeley, WW; Seo, SW; Spina, S | 1 |
Chen, J; Dong, C; Jing, J; Xie, J; Zhang, F; Zhang, Y; Zhao, L; Zhong, R | 1 |
Krause, BJ; Kuhla, A; Lindner, T; Müller, L; Power Guerra, N; Rühlmann, C; Stenzel, J; Teipel, S; Vollmar, B | 1 |
Aliaga, A; Cuello, AC; Dea, D; Do Carmo, S; Fonov, VS; Gauthier, S; Kang, MS; Kostikov, A; Mathieu, A; Parent, MJ; Poirier, J; Rosa-Neto, P; Shin, M; Soucy, JP; Zimmer, ER | 1 |
Bauckneht, M; Morbelli, S | 1 |
Cai, L; Gao, S; Ji, Y; Li, Y; Shi, Z; Wang, Y; Xing, X; Yang, H; Yao, S; Zhang, N | 1 |
Baran, TM; Lin, FV | 1 |
Arbizu, J; Boada, M; Martínez-Lage, P; Monleón, I; Munuera, J; Pérez-Grijalba, V; Pesini, P; Romero, J; Ruiz, A; San-José, I; Sarasa, L; Sarasa, M; Tárraga, L | 1 |
Jagust, WJ; Madison, C; Oh, H; Ossenkoppele, R; van Berckel, BN; Wirth, M | 1 |
Kung, HF; Ploessl, K; Zhu, L | 1 |
Duong, TQ; Yu, F; Zhou, Y | 1 |
Adriaanse, SM; Barkhof, F; Boellaard, R; Lammertsma, AA; Ossenkoppele, R; Reuter, M; Scheltens, P; Tolboom, N; van Berckel, BN; van der Flier, WM; van Dijk, KR; Windhorst, AD; Yaqub, M; Zwan, MD | 1 |
Bowen, CV; Brown, RE; Burrell, S; Darvesh, S; DeBay, DR; Jollymore, CT; Macdonald, IR; Martin, E; Mawko, G; O'Leary, TP; Reid, GA | 1 |
Benzinger, TL; Devous, MD; Jagust, WJ; Johnson, KA; Klunk, WE; Koeppe, RA; Mathis, CA; Minhas, D; Mintun, MA; Pontecorvo, MJ; Price, JC; Rowe, CC; Skovronsky, DM | 1 |
Arzberger, T; Drzezga, A; Förster, S; Grimmer, T; Henriksen, G; Manook, A; Schwaiger, M; von Reutern, B; Wester, HJ; Yousefi, BH | 1 |
Bartenstein, P; Brendel, M; Delker, A; Pogarell, O; Rominger, A; Xiong, G | 1 |
Unschuld, PG | 1 |
Altmann, A; Greicius, MD; Jagust, WJ; Landau, SM; Ng, B | 1 |
Almkvist, O; Carter, SF; Graff, C; Långström, B; Nordberg, A; Rodriguez-Vieitez, E; Schöll, M; Thordardottir, S; Wall, A; Westman, E | 1 |
Mintun, MA | 1 |
Cross, DJ; Galasko, D; Minoshima, S; Peskind, ER; Petrie, EC; Raskind, MA; Schellenberg, GD | 1 |
Hattori, N; Ishii, K; Kambe, T; Motoi, Y | 1 |
Arai, H; Furukawa, K; Furumoto, S; Iwata, R; Kudo, Y; Okamura, N; Tashiro, M; Waragai, M; Yanai, K | 1 |
Cho, SJ; Kim, SH; Kim, SJ; Kim, YB; Lee, SY; Shin, J | 1 |
Alexopoulos, P; Drzezga, A; Förschler, A; Förstl, H; Grimmer, T; Henriksen, G; Klunk, WE; Kurz, A; Mathis, CA; Perneczky, R; Sorg, C; Tholen, S; Yousefi, BH | 1 |
Almkvist, O; Bogdanovic, N; Långström, B; Nordberg, A; Schöll, M; Viitanen, M; Wall, A | 1 |
Ataka, S; Miki, T; Mori, H; Shimada, H; Takechi, H; Tomiyama, T | 1 |
Abbas, A; Barré, L; Delamare, J; Dhilly, M; Guilloteau, D; Moustié, O; Poisnel, G | 1 |
Barrio, JR; Bookheimer, SY; Ercoli, LM; Huang, SC; Kepe, V; Lavretsky, H; Miller, KJ; Siddarth, P; Silverman, DH; Small, GW | 1 |
Dauar, MT; Fonov, V; Gauthier, S; Jia, J; Leuzy, A; Mohades, S; Rosa-Neto, P; Rowley, J; Shin, M; Wu, L | 1 |
Corbetta-Rastelli, C; Ghosh, PM; Gorno-Tempini, ML; Greicius, MD; Jagust, WJ; Laforce, R; Lehmann, M; Madison, C; Miller, BL; Rabinovici, GD; Rosen, HJ; Seeley, WW; Weiner, MW | 1 |
Clark, JC; Davies, JR; Fryer, TD; Gillard, JH; Graves, MJ; Kirkpatrick, PJ; Rudd, JH; Warburton, EA; Weissberg, PL | 1 |
Barrio, JR; Kepe, V; Small, GW | 1 |
Barrio, JR; Bookheimer, SY; Burggren, AC; Cole, GM; Ercoli, LM; Huang, SC; Kepe, V; Lavretsky, H; Miller, KJ; Phelps, ME; Satyamurthy, N; Siddarth, P; Small, GW; Thompson, PM; Vinters, HV | 1 |
Almkvist, O; Blomquist, G; Engler, H; Forsberg, A; Hagman, G; Långström, B; Nordberg, A; Ringheim, A; Wall, A | 1 |
DeKosky, S; Diehl-Schmid, J; Drzezga, A; Grimmer, T; Henriksen, G; Klunk, WE; Kurz, A; Mathis, CA; Perneczky, R; Price, J; Schwaiger, M; Stangier, I; Wester, HJ | 1 |
Aalto, S; Karrasch, M; Kemppainen, NM; Någren, K; Oikonen, V; Parkkola, R; Rinne, JO; Savisto, N; Viitanen, M | 1 |
4 review(s) available for fluorodeoxyglucose f18 and Amyloid Deposits
Article | Year |
---|---|
Imaging Carotid Plaque Inflammation Using Positron Emission Tomography: Emerging Role in Clinical Stroke Care, Research Applications, and Future Directions.
Topics: Animals; Coleoptera; Constriction, Pathologic; Fluorodeoxyglucose F18; Inflammation; Plaque, Amyloid; Plaque, Atherosclerotic; Positron-Emission Tomography; Stroke | 2023 |
[Possibilities of modern imaging technologies in early diagnosis of Alzheimer disease].
Topics: Aged; Alzheimer Disease; Atrophy; Brain; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Plaque, Amyloid; Positron-Emission Tomography; Switzerland | 2015 |
FDG and amyloid positron emission tomography.
Topics: Aged; Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Seeing is believing: neuroimaging adds to our understanding of cerebral pathology.
Topics: Aging; Alzheimer Disease; Brain; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Enhancement; Plaque, Amyloid; Positron-Emission Tomography | 2006 |
2 trial(s) available for fluorodeoxyglucose f18 and Amyloid Deposits
Article | Year |
---|---|
Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Amyloid; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Plaque, Amyloid; Positron-Emission Tomography | 2012 |
Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography | 2005 |
35 other study(ies) available for fluorodeoxyglucose f18 and Amyloid Deposits
Article | Year |
---|---|
Effects of Alzheimer and Lewy Body Disease Pathologies on Brain Metabolism.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Plaque, Amyloid; Positron-Emission Tomography | 2022 |
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Amyloid; Atrophy; Brain; Cognition; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Inheritance Patterns; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Phosphorylation; Plaque, Amyloid; Solubility; tau Proteins | 2020 |
Synchronous nonmonotonic changes in functional connectivity and white matter integrity in a rat model of sporadic Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Brain; Demyelinating Diseases; Diabetes Mellitus, Experimental; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Fluorodeoxyglucose F18; Functional Neuroimaging; Glucose; Injections, Intraventricular; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neural Pathways; Neurofibrillary Tangles; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Streptozocin; White Matter | 2021 |
Diagnostic Accuracy of Amyloid versus
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Autopsy; Brain; DNA-Binding Proteins; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Frontotemporal Lobar Degeneration; Humans; Male; Middle Aged; Pick Disease of the Brain; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; tau Proteins; Thiazoles | 2021 |
Correlation Between Brain 18F-AV45 and 18F-FDG PET Distribution Characteristics and Cognitive Function in Patients with Mild and Moderate Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Cognition; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Male; Mental Status and Dementia Tests; Neuroimaging; Plaque, Amyloid; Positron-Emission Tomography; Severity of Illness Index | 2021 |
Long-Term Caloric Restriction Attenuates β-Amyloid Neuropathology and Is Accompanied by Autophagy in APPswe/PS1delta9 Mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animal Nutritional Physiological Phenomena; Animals; Aspartic Acid; Autophagy; Calcium-Binding Proteins; Caloric Restriction; Cerebral Cortex; Creatine; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Hippocampus; Magnetic Resonance Spectroscopy; Maze Learning; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Neurons; Plaque, Amyloid; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Animals; Animals, Genetically Modified; Biomarkers; Brain; Brain Chemistry; Cognitive Dysfunction; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Male; Memory Disorders; Multimodal Imaging; Mutation; Neuroimaging; Plaque, Amyloid; Positron-Emission Tomography; Protein Aggregation, Pathological; Radiopharmaceuticals; Rats; Rats, Transgenic; Rats, Wistar | 2017 |
Amyloid PET Imaging: Standardization and Integration with Other Alzheimer's Disease Biomarkers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Stilbenes; Thiazoles | 2018 |
Spatial Patterns of Hypometabolism and Amyloid Deposition in Variants of Alzheimer's Disease Corresponding to Brain Networks: a Prospective Cohort Study.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Benzothiazoles; Brain; Brain Diseases, Metabolic; Carbon Radioisotopes; Case-Control Studies; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Plaque, Amyloid; Positron-Emission Tomography; Thiazoles; Time Factors; Tissue Distribution | 2019 |
Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Aging; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Plaque, Amyloid; Positron-Emission Tomography | 2018 |
Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoproteins E; Biomarkers; Case-Control Studies; Cognitive Dysfunction; Cross-Sectional Studies; Early Diagnosis; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; Neuroimaging; Peptide Fragments; Phosphorylation; Plaque, Amyloid; Positron-Emission Tomography; Prodromal Symptoms; tau Proteins; Thiazoles | 2019 |
Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function?
Topics: Aged; Brain; Cross-Sectional Studies; Executive Function; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Memory, Episodic; Memory, Short-Term; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Semantics; Speech Perception; Visual Perception | 2014 |
Chemistry. Expanding the scope of fluorine tags for PET imaging.
Topics: Alzheimer Disease; Aniline Compounds; Celecoxib; Ethylene Glycols; Fluorescent Dyes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluoxetine; Glucose; Halogenation; Humans; Melanoma; Neoplasms; Patient Selection; Plaque, Amyloid; Positron-Emission Tomography; Pyrazoles; Radiopharmaceuticals; Sulfonamides | 2013 |
White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's disease patients.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Rest; White Matter | 2015 |
The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2014 |
Early detection of cerebral glucose uptake changes in the 5XFAD mouse.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cerebral Cortex; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Transgenic; Mutation; Plaque, Amyloid; Positron-Emission Tomography; Presenilin-1; Tomography Scanners, X-Ray Computed | 2014 |
The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Calibration; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2015 |
Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
Topics: Aged; Aged, 80 and over; Aniline Compounds; Animals; Autoradiography; Benzothiazoles; Brain; Carbon Isotopes; Fluorodeoxyglucose F18; Humans; Imidazoles; Male; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography; Rats; Thiazoles; Tissue Distribution | 2015 |
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cognitive Dysfunction; Depression; Female; Fluorodeoxyglucose F18; Humans; Male; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Regional brain hypometabolism is unrelated to regional amyloid plaque burden.
Topics: Aged; Aniline Compounds; Atrophy; Brain; Case-Control Studies; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Plaque, Amyloid; Positron-Emission Tomography | 2015 |
Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography.
Topics: Age of Onset; Aged; Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Genes, Dominant; Genotype; Gliosis; Humans; Male; Memory, Episodic; Middle Aged; Mutation; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Principal Component Analysis | 2015 |
Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cerebrospinal Fluid; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neurofibrillary Tangles; Peptide Fragments; Plaque, Amyloid; Positron-Emission Tomography; Predictive Value of Tests; tau Proteins | 2009 |
Posterior cortical atrophy with [11C] Pittsburgh compound B accumulation in the primary visual cortex.
Topics: Aniline Compounds; Atrophy; Brain Mapping; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Hemianopsia; Humans; Magnetic Resonance Imaging; Middle Aged; Neurofibrillary Tangles; Plaque, Amyloid; Positron-Emission Tomography; Predictive Value of Tests; Thiazoles; Vision Disorders; Visual Cortex | 2010 |
Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.
Topics: Aged; Alzheimer Disease; Amyloid; Benzoxazoles; Brain; Brain Mapping; Carbon Radioisotopes; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Plaque, Amyloid; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Thiazoles | 2010 |
Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Brain Mapping; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neurofibrillary Tangles; Nitriles; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Signal Processing, Computer-Assisted; Thiazoles | 2010 |
Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Apolipoprotein E4; Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2010 |
Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Status Schedule; Methionine; Middle Aged; Mutation; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Postmortem Changes; Presenilin-1; Statistics as Topic; Time Factors; Valine | 2011 |
Clinical course of patients with familial early-onset Alzheimer's disease potentially lacking senile plaques bearing the E693Δ mutation in amyloid precursor protein.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Aniline Compounds; Apolipoproteins E; Atrophy; Benzothiazoles; Brain; Cerebellar Ataxia; Cognition; Disease Progression; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Memory Disorders; Middle Aged; Mutation; Neuropsychological Tests; Pedigree; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2011 |
PET imaging with [18F]AV-45 in an APP/PS1-21 murine model of amyloid plaque deposition.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Autoradiography; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Plaque, Amyloid; Positron-Emission Tomography | 2012 |
Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging.
Topics: Aged; Aged, 80 and over; Cerebellum; Cluster Analysis; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibrillary Tangles; Nitriles; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment; Risk Factors | 2012 |
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Phenotype; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
PET of brain amyloid and tau in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Case-Control Studies; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurofibrillary Tangles; Nitriles; Plaque, Amyloid; Positron-Emission Tomography; tau Proteins | 2006 |
PET imaging of amyloid deposition in patients with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Cerebral Cortex; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Thiazoles | 2008 |
Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Brain; Brain Chemistry; Dementia; Female; Fluorodeoxyglucose F18; Functional Laterality; Genotype; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2008 |
Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Carbon Radioisotopes; Cerebral Cortex; Cerebrovascular Circulation; Disease Susceptibility; Educational Status; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Recovery of Function; Thiazoles | 2008 |